Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Champix 0.5mg Tablet - EU/1/06/360/01
- Epaclob 1mg/ml Oral Suspension - PA0549/026/001
- Epaclob 2mg/ml Oral Suspension - PA0549/026/002
- Furosemide 50mg/5ml Solution for Injection - PA0073/059/005
- Perinal Cutaneous Spray hydrocortisone 0.2% w/w / lidocaine hydrochloride monohydrate 1.0% w/w - PA0278/017/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Denzapine 50mg/ml Oral Suspension - PA0126/235/005
- Losartan Hydrochlorothiazide 50mg/12.5mg Tablet - PA0749/026/001
- Losartan Teva 100mg Film Coated Tablets - PA0749/090/004
- Metformin Teva 500mg Film Coated Tablets - PA0749/185/001
- Morphine Sulphate 10mg/ml Solution for Injection - PA0073/020/001
- Praxbind 50mcg/ml Solution for Injection/Infusion - EU/1/15/1056/001
- Vedixal XL 150mg Prolonged Release Capsule - PA1445/016/002
- Voriconazole 200mg Powder for Solution for Infusion - PA2059/020/001
- Xeljanz 10mg Tablets - EU/1/17/1178/007
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.